Enmetazobactam was first discovered by Orchid ... to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate, EXBLIFEP ® (cefepime/enmetazobactam ...

CHENNAI, (IANS) – Vertically integrated pharma player Orchid Pharma Ltd said on February 23 that it will launch its Enmetazobactam drug in the US in the next couple of quarters. The company has ...

Orchid Pharma Limited recently announced the launch of its new drug – Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital ...

Enmetazobactam was invented in India by Orchid and then out-licensed to Allecra Therapeutics for further development.

The drug firm has received new drug approval from the US Food and Drug Administration (USFDA) for Enmetazobactam, Orchid Pharma said in a statement. The approval paves the way for the introduction ...